SC-59735,
Tifacogin,
N-Benzyl-1-(thiophen-2-yl)methanamine,
Benzyl(thiophen-2-ylmethyl)amine,
148883-56-1,
73325-61-8,
benzylthiophen-2-ylmethylamine,
1-phenyl-N-(thiophen-2-ylmethyl)methanamine,
benzyl(2-thienylmethyl)amine,
AC1LIT3J,
ACMC-1C9I5,
SCHEMBL3625005,
N-Benzylthiophene-2-methaneamine,
2-Thienyl N-benzyl methyl amine,
CTK5J6362,
ZINC570898,
ALBB-019258,
1393AC,
ANW-21167,
MFCD01764729,
STK510839,
AKOS000226216,
BENZYL-THIOPHEN-2-YLMETHYLAMINE,
MCULE-2526444279,
AJ-23557,
DB-042956,
TC-109912,
FT-0643425,
ST24025620,
ST45175138,
V3406,
B-7296,
Blood-coagulationfactor laci(human clone lp9 protein moiety reduced),N-L-alanyl-,
Tifacogin,
LACI,
LACI, Searle/Chiron,
RTFPI, Searle/Chiron,
LACI, Pharmacia/Chiron,
Tifacogin [USAN:INN],
RTFPI, Pharmacia/Chiron,
D0B7VK,
UNII-415ZN8YW42,
C12H13NS,
TFP-561,
CID961320,
BENZYL-THIOPHEN-2-YLMETHYL-AMINE,
SC 59735,
SC-59735,
Tissue factor pathway inhibitor, Searle/Chiron,
Tissue factor pathway inhibitor, Pharmacia/Chiron,
Lipoprotein associated coagulation inhibitor, Searle/Chiron,
Lipoprotein associated coagulation inhibitor, Pharmacia/Chiron,